stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Galenica AG

Switzerland · SIX: GALE.SW · Market cap: · P/E: · P/S:

Galenica runs pharmacies and distributes medicines and health products across Switzerland, plus logistics and IT services for healthcare companies.

Galenica is the company behind many of the pharmacies you see on Swiss high streets, and it also moves medicines and health products around the country. It serves ordinary shoppers who buy vitamins, cosmetics, and over-the-counter remedies, patients picking up prescriptions, and the doctors, pharmacies, and healthcare firms that need products delivered reliably. Most people know it through its store brands rather than the Galenica name itself.

Galenica AG (GALE.SW) Swiss pharmacy wholesale and pharmacy network: line art illustration of a pharmacist behind a pharmacy counter handing medicine over to a customer
Swiss pharmacy wholesale and pharmacy network
Galenica runs pharmacies and supplies medicines to many Swiss pharmacies.

The business splits into two main parts. One is the pharmacy side, built around the Amavita, Sun Store, and Coop Vitality chains, which sell health, beauty, and wellness products directly to customers. The other is distribution and services: Galenica supplies medicines and health products to pharmacies, doctors, and hospitals, and runs the logistics and IT that keep those shelves stocked and records moving. Think of it as both a retailer and the delivery system behind thousands of Swiss health counters. Its position is strong because Switzerland's pharmacy and drug-distribution market is tightly regulated and hard to break into. Galenica's distribution network reaches a huge share of the country's pharmacies, giving it scale that smaller rivals struggle to match. That reach makes it a natural partner for drugmakers and healthcare companies that need their products in front of Swiss customers. The pharmacy chains also give it a direct relationship with shoppers, which helps it sell more of its own and partner brands.


The company is not without strains. Pharmacy retail is competitive, margins on medicines are watched closely by regulators, and online sellers and discounters keep pressure on prices. Galenica also has to keep investing in IT and logistics to stay useful to its healthcare customers. Still, it generates steady cash from a business people need in good times and bad, and it pays much of that back to shareholders through dividends. It is a quiet, dependable Swiss healthcare machine rather than a fast-growing story.

Saved answer · last researched 14 Nov 2026